Literature DB >> 21908575

Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.

Jesmin Akter1, Atsushi Takatori, Md Shamim Hossain, Toshinori Ozaki, Atsuko Nakazawa, Miki Ohira, Yusuke Suenaga, Akira Nakagawara.   

Abstract

PURPOSE: Our previous study showed that expression of NLRR3 is significantly high in favorable neuroblastomas (NBL), whereas that of NLRR1 is significantly high in unfavorable NBLs. However, the molecular mechanism of transcriptional regulation of NLRR3 remains elusive. This study was undertaken to clarify the transcriptional regulation of NLRR3 and its association with the prognosis of NBL. EXPERIMENTAL
DESIGN: NLRR3 and MYCN expressions in NBL cell lines were analyzed after induction of cell differentiation, MYCN knockdown, and overexpression. The transcriptional regulation of NLRR3 was analyzed by luciferase reporter and chromatin immunoprecipitation assays. Quantitative PCR was used for examining the expression of NLRR3, Miz-1, or MYCN in 87 primary NBLs.
RESULTS: The expression of NLRR3 mRNA was upregulated during differentiation of NBL cells induced by retinoic acid, accompanied with reduced expression of MYCN, suggesting that NLRR3 expression was inversely correlated with MYCN in differentiation. Indeed, knockdown of MYCN induced NLRR3 expression, whereas exogenously expressed MYCN reduced cellular NLRR3 expression. We found that Miz-1 was highly expressed in favorable NBLs and NLRR3 was induced by Miz-1 expression in NBL cells. MYCN and Miz-1 complexes bound to NLRR3 promoter and showed a negative regulation of NLRR3 expression. In addition, a combination of low expression of NLRR3 and high expression of MYCN was highly associated with poor prognosis.
CONCLUSIONS: NLRR3 is a direct target of MYCN, which associates with Miz-1 and negatively regulates NLRR3 expression. NLRR3 may play a role in NBL differentiation and the survival of NBL patients by inversely correlating with MYCN amplification. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21908575     DOI: 10.1158/1078-0432.CCR-11-0313

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  11 in total

Review 1.  Family matters: How MYC family oncogenes impact small cell lung cancer.

Authors:  Johannes Brägelmann; Stefanie Böhm; Matthew R Guthrie; Gurkan Mollaoglu; Trudy G Oliver; Martin L Sos
Journal:  Cell Cycle       Date:  2017-07-24       Impact factor: 4.534

Review 2.  Neuroblastoma and MYCN.

Authors:  Miller Huang; William A Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

3.  ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma.

Authors:  Md Kamrul Hasan; Asmaa Nafady; Atsushi Takatori; Satoshi Kishida; Miki Ohira; Yusuke Suenaga; Shamim Hossain; Jesmin Akter; Atsushi Ogura; Yohko Nakamura; Kenji Kadomatsu; Akira Nakagawara
Journal:  Sci Rep       Date:  2013-12-20       Impact factor: 4.379

4.  Miz-1 activates gene expression via a novel consensus DNA binding motif.

Authors:  Bonnie L Barrilleaux; Dana Burow; Sarah H Lockwood; Abigail Yu; David J Segal; Paul S Knoepfler
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

5.  Essential role of GATA3 in regulation of differentiation and cell proliferation in SK-N-SH neuroblastoma cells.

Authors:  Hongwei Peng; Xiao-Xue Ke; Renjian Hu; Liqun Yang; Hongjuan Cui; Yuquan Wei
Journal:  Mol Med Rep       Date:  2014-10-29       Impact factor: 2.952

6.  Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.

Authors:  Afzal Sheikh; Atsushi Takatori; Md Shamim Hossain; Md Kamrul Hasan; Masatoshi Tagawa; Hiroki Nagase; Akira Nakagawara
Journal:  Cancer Sci       Date:  2016-09-02       Impact factor: 6.716

7.  NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers.

Authors:  Atsushi Takatori; Md Shamim Hossain; Atsushi Ogura; Jesmin Akter; Yohko Nakamura; Akira Nakagawara
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

8.  MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coin.

Authors:  Samuele Gherardi; Emanuele Valli; Daniela Erriquez; Giovanni Perini
Journal:  Front Oncol       Date:  2013-03-11       Impact factor: 6.244

9.  Apoptotic cell death in neuroblastoma.

Authors:  Yuanyuan Li; Akira Nakagawara
Journal:  Cells       Date:  2013-06-20       Impact factor: 6.600

10.  Biphasic influence of Miz1 on neural crest development by regulating cell survival and apical adhesion complex formation in the developing neural tube.

Authors:  Laura Kerosuo; Marianne E Bronner
Journal:  Mol Biol Cell       Date:  2013-12-04       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.